Phase 1A/1B Study of PSA/IL-2/GM-CSF Vaccine for Recurrent Prostate Cancer in Hormone Naive and Hormone Independent Patients
Clinical trial NCT02058680 · UNKNOWN
Trial details
- NCT number
- NCT02058680
- Sponsor
- OncBioMune Pharmaceuticals
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-04-01
- Primary completion
- 2018-12-01
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.